Tandem Native Mass-Spectrometry on Antibody-Drug Conjugates and Submillion Da Antibody-Antigen Protein Assemblies on an Orbitrap EMR Equipped with a High-Mass Quadrupole Mass Selector.
暂无分享,去创建一个
P. Parren | A. Heck | A. Makarov | M. Belov | R. D. de Jong | A. Dyachenko | Guanbo Wang | E. T. van den Bremer
[1] J. Shabanowitz,et al. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] Albert J R Heck,et al. Investigation of intact protein complexes by mass spectrometry. , 2004, Mass spectrometry reviews.
[3] M. Sliwkowski,et al. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates , 2012, Nature Biotechnology.
[4] S. Alley,et al. Analytical and bioanalytical technologies for characterizing antibody-drug conjugates. , 2013, Current opinion in chemical biology.
[5] J. Reichert,et al. Antibody-drug conjugates , 2013, mAbs.
[6] Natalie J. Thompson,et al. Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry. , 2012, Angewandte Chemie.
[7] Damon L. Meyer,et al. Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate , 2004, Clinical Cancer Research.
[8] John F. Valliere-Douglass,et al. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry. , 2015, Molecular pharmaceutics.
[9] P. Cramer,et al. Structural biology of RNA polymerase III: mass spectrometry elucidates subcomplex architecture. , 2007, Structure.
[10] Jared B Shaw,et al. Complete protein characterization using top-down mass spectrometry and ultraviolet photodissociation. , 2013, Journal of the American Chemical Society.
[11] Christian Bailly,et al. The next generation of antibody-drug conjugates comes of age. , 2010, Discovery medicine.
[12] Alain Van Dorsselaer,et al. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment. , 2014, Analytical chemistry.
[13] P. Parren,et al. In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap , 2013, mAbs.
[14] Aditya A Wakankar,et al. Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.
[15] W. J. Galush,et al. Profiling antibody drug conjugate positional isomers: a system-of-equations approach. , 2012, Analytical chemistry.
[16] G. Vidarsson,et al. Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange , 2014, The Journal of Biological Chemistry.
[17] Mohammed Shameem,et al. Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications , 2014, mAbs.
[18] W. Roos,et al. Probing the biophysical interplay between a viral genome and its capsid. , 2013, Nature chemistry.
[19] John F. Valliere-Douglass,et al. Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues. , 2012, Analytical chemistry.
[20] A. Heck,et al. Analytical approaches for size and mass analysis of large protein assemblies. , 2014, Annual review of analytical chemistry.
[21] François Debaene,et al. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. , 2013, Analytical chemistry.
[22] A. Beck,et al. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[23] Albert J R Heck,et al. High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies , 2012, Nature Methods.
[24] C. Robinson,et al. Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] Kenneth C. Anderson,et al. Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors , 2011, The Journal of Immunology.
[26] A. Heck,et al. Defining the Stoichiometry and Cargo Load of Viral and Bacterial Nanoparticles by Orbitrap Mass Spectrometry , 2014, Journal of the American Chemical Society.
[27] Piet Gros,et al. Complement Is Activated by IgG Hexamers Assembled at the Cell Surface , 2014, Science.
[28] Paul Polakis,et al. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index , 2008, Nature Biotechnology.
[29] A. Younes,et al. Brentuximab Vedotin (SGN-35) , 2011, Clinical Cancer Research.
[30] R. Chari,et al. Antibody-drug conjugates: an emerging concept in cancer therapy. , 2014, Angewandte Chemie.
[31] John F. Valliere-Douglass,et al. Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry. , 2014, Analytical chemistry.
[32] A. Heck,et al. Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry , 2014, Nature Protocols.
[33] N. Kelleher,et al. From protein complexes to subunit backbone fragments: a multi-stage approach to native mass spectrometry. , 2013, Analytical chemistry.
[34] Peter G Schultz,et al. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids , 2012, Proceedings of the National Academy of Sciences.
[35] M. B. Denton,et al. The quadrupole mass filter: Basic operating concepts , 1986 .
[36] John F. Valliere-Douglass,et al. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry. , 2014, Analytical chemistry.
[37] M. Dorywalska,et al. Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates. , 2013, Chemistry & biology.
[38] S. Sanglier-Cianférani,et al. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. , 2009, Analytical chemistry.
[39] S. Bhakta,et al. Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers. , 2013, Methods in molecular biology.
[40] P. Parren,et al. Quantitative analysis of the interaction strength and dynamics of human IgG4 half molecules by native mass spectrometry. , 2011, Structure.
[41] Natalie J. Thompson,et al. Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry , 2014, mAbs.
[42] J. Queiroz,et al. Hydrophobic interaction chromatography of proteins. , 2001, Journal of biotechnology.
[43] Hongcheng Liu,et al. Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. , 2010, Analytical chemistry.